Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
The Impact of Obesity on Breast Cancer Diagnosis and Treatment
Kyuwan Lee et al.
CURRENT ONCOLOGY REPORTS (2019)
Statin use and breast cancer survival - a Swedish nationwide study
Signe Borgquist et al.
BMC CANCER (2019)
Statin use and risk of contralateral breast cancer: a nationwide cohort study
Rikke Langballe et al.
BRITISH JOURNAL OF CANCER (2018)
The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016
Maj-Britt Jensen et al.
ACTA ONCOLOGICA (2018)
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study
Signe Borgquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study
Deirdre P. Cronin-Fenton et al.
ACTA ONCOLOGICA (2017)
Data Resource Profile: Danish online drug use statistics (MEDSTAT)
Morten Schmidt et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
Statin Use After Diagnosis of Breast Cancer and Survival A Population-based Cohort Study
Chris R. Cardwell et al.
EPIDEMIOLOGY (2015)
Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome Opportunities for Improvement
Benjamin J. Hirsh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
Denise M. Boudreau et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer
D. P. McDonnell et al.
CLIMACTERIC (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Statins and breast cancer prognosis: evidence and opportunities
Thomas P. Ahern et al.
LANCET ONCOLOGY (2014)
On Estrogen, Cholesterol Metabolism, and Breast Cancer
Margaret Warner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland
Teemu J. Murtola et al.
PLOS ONE (2014)
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
Volker Ziller et al.
BMC CANCER (2013)
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
B. Makubate et al.
BRITISH JOURNAL OF CANCER (2013)
Lifestyle Profile Among Statin Users
Reimar Wernich Thomsen et al.
EPIDEMIOLOGY (2013)
Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
Stefan Nickels et al.
PLOS ONE (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Qian Wu et al.
CELL REPORTS (2013)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
Young Kwang Chae et al.
CANCER INVESTIGATION (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Impact of Obesity on Cardiovascular Disease
Kerstyn C. Zalesin et al.
MEDICAL CLINICS OF NORTH AMERICA (2011)
The Danish National Patient Register
Elsebeth Lynge et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
The Danish Civil Registration System
Carsten Bocker Pedersen
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
NORDCAN - a Nordic tool for cancer information, planning, quality control and research
Gerda Engholm et al.
ACTA ONCOLOGICA (2010)
Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
Ivana Sestak et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women
Mina Ha et al.
CANCER CAUSES & CONTROL (2009)
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Qian Zhou et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
Henning Mouridsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Incorporating Tailored Interactive Patient Solutions Using Interactive Voice Response Technology to Improve Statin Adherence: Results of a Randomized Clinical Trial in a Managed Care Setting
Jane N. Stacy et al.
POPULATION HEALTH MANAGEMENT (2009)
The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise
Susanne Moller et al.
ACTA ONCOLOGICA (2008)
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users
Anjali S. Kumar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Physician follow-up and provider continuity are associated with long-term medication adherence - A study of the dynamics of statin use
M. Alan Brookhart et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Application of lag-time into exposure definitions to control for protopathic bias
H. Tamim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Breast cancer growth prevention by statins
Michael J. Campbell et al.
CANCER RESEARCH (2006)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Therapy Insight: potential of statins for cancer chemoprevention and therapy
MS Katz
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
Statins: mechanism of action and effects
C Stancu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)